Form 10-Q · Quarterly report
McKesson Corporation 10-Q, filed Nov 4, 2026
- Filed
- CIK
- 0000927653
- Accession no.
- 0000927653-26-000281
Summary
McKesson reported an 8% increase in revenues and diluted earnings per share of $10.44 for the quarter ended September 30, 2026, and detailed several transactions including the acquisition of Precision Medicine Group for about $2.25 billion, a controlling stake in Spectrum Vision Partners, and a $1.4 billion agreement to acquire 49% of Option Care Health. The company also completed a $1.25 billion minority investment by Apollo Funds in its Medical-Surgical Solutions segment as part of a planned separation.
Key points
- McKesson's revenues rose 8% and gross profit rose 12% for both the three and six months ended September 30, 2026, with diluted earnings per share of $10.44 for the quarter, up from $8.92 a year earlier.
- In early November, McKesson completed the acquisition of Precision Medicine Group for about $2.25 billion and acquired a controlling interest in Spectrum Vision Partners for about $525 million.
- On October 5, 2026, McKesson agreed to acquire a 49% minority interest in Option Care Health for approximately $1.4 billion, with Clayton, Dubilier & Rice holding the remaining 51%.
- Apollo Funds invested approximately $1.25 billion for convertible preferred equity representing about 13% of McKesson's Medical-Surgical Solutions segment, which McKesson intends to separate into an independent company.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Executive Summary 38 Trends and Uncertainties 39 Overview of Consolidated Results 39 Overview of Segment Results 44 New Accounting Pronouncements 47 Financial Condition, Liquidity, and Capital Resources 48 Cautionary Notice About Forward-Looking Statements 52 Available Information 52 GENERAL Management’s discussion and analysis of financial condition and results of operations, referred to as the “Financial Review,” is intended to assist the reader in the understanding and assessment of significant changes and trends related to the results of operations and financial position of McKesson Corporation together with its subsidiaries (collectively, the “Company,”…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.